<html>
<head>
<title>Koneksa’s $45 million round could help make at-home clinical trials a reality – TechCrunch</title>
<link href="../Styles/Style.css" type="text/css" rel="stylesheet"/>
</head>
<body>
<h1 class="translated">Koneksa 的 4500 万美元融资可能有助于实现家庭临床试验——TechCrunch</h1>
<blockquote>原文：<a href="https://web.archive.org/web/https://techcrunch.com/2022/02/07/koneksas-45-million-round-could-help-make-at-home-clinical-trials-a-reality/amp/">https://web.archive.org/web/https://techcrunch.com/2022/02/07/koneksas-45-million-round-could-help-make-at-home-clinical-trials-a-reality/amp/</a></blockquote><div><div class="content">

			
	
		
		

		<p class="amp-featured-image translated"><amp-img src="https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/GettyImages-936129188.jpg?w=1024" class="attachment-post-thumbnail size-post-thumbnail wp-post-image amp-wp-enforced-sizes i-amphtml-layout-intrinsic i-amphtml-layout-size-defined" alt="" srcset="https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/GettyImages-936129188.jpg 7999w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/GettyImages-936129188.jpg?resize=150,75 150w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/GettyImages-936129188.jpg?resize=300,150 300w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/GettyImages-936129188.jpg?resize=768,384 768w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/GettyImages-936129188.jpg?resize=680,340 680w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/GettyImages-936129188.jpg?resize=1536,768 1536w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/GettyImages-936129188.jpg?resize=2048,1024 2048w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/GettyImages-936129188.jpg?resize=50,25 50w" layout="intrinsic" i-amphtml-layout="intrinsic"> <i-amphtml-sizer class="i-amphtml-sizer"> <img alt="" aria-hidden="true" class="i-amphtml-intrinsic-sizer" role="presentation" src=""/> </i-amphtml-sizer> <noscript> <img src="../Images/b1e8e0cd098c131c7770ff88ac67c9e4.png" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" loading="lazy" srcset="https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/GettyImages-936129188.jpg 7999w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/GettyImages-936129188.jpg?resize=150,75 150w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/GettyImages-936129188.jpg?resize=300,150 300w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/GettyImages-936129188.jpg?resize=768,384 768w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/GettyImages-936129188.jpg?resize=680,340 680w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/GettyImages-936129188.jpg?resize=1536,768 1536w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/GettyImages-936129188.jpg?resize=2048,1024 2048w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/GettyImages-936129188.jpg?resize=50,25 50w" sizes="(max-width: 1024px) 100vw, 1024px" data-original-src="https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/GettyImages-936129188.jpg?w=1024"/> </noscript> </amp-img></p><p class="translated"><strong>图片来源:</strong> Getty Images</p><p class="translated">用数字对症状进行评级似乎很容易，但可能比看起来要难。你踢到脚趾时有多痛？是满分 10 分中的 2 分吗？四分。你晚上多久醒来一次？两次，三次？定期吗？很少？</p>
<p class="translated">这些不精确的自我报告的尺度在医学中随处可见，甚至与风险比碰伤的脚趾甲更高的疾病有关。【Koneksa 成立于 2013 年，致力于发现和验证临床生物标志物。这一过程始于将模拟秤数字化，并在此过程中对其进行改进。</p>
<p class="translated">Koneksa 开发了一个软件套件，可用于各种设备，从便携式肺活量计到 iPhones 和苹果手表。这些设备捕捉数据，软件从这些数据中收集临床有用的信号，并将其组织起来，供进行临床试验的制药公司或医疗保健提供商审查。</p>
<p class="translated">在几项研究的支持下，并在 700 多个地点进行临床试验，Koneksa 宣布 C 轮融资 4500 万美元。到目前为止，该公司相对节俭，在首轮融资和种子资金中筹集了 400 万美元，在 b 轮融资中筹集了 1600 万美元。</p>
<p class="translated">这一轮将是迎来 CMO·约翰·瓦格纳所说的数字生物标记世界“拐点”的一大推动力的一部分。(Wagner 在 Cynga、Merck、Takeda 和 Foresite Capital 工作过之后来到了 Koneksa。他还编辑了《临床和转化科学》杂志。)</p>
<p class="translated">“众所周知，你进行的测量越多，你获得的准确性就越高，临床试验的力量就越大。这使得(试验)规模更小、速度更快、效率更高，”瓦格纳告诉 TechCrunch。“我喜欢把它看作是静态照片和视频之间的区别。静态照片很棒，但是视频可以讲述整个故事。这就是我们对数字生物标记的看法:与传统生物标记相比，它们讲述了整个故事。”</p>
<p/><div id="attachment_2266722" class="wp-caption alignnone amp-wp-e2bc858" data-amp-original-style="width: 1034px"><amp-img aria-describedby="caption-attachment-2266722" class="size-full wp-image-2266722 amp-wp-enforced-sizes i-amphtml-layout-intrinsic i-amphtml-layout-size-defined" src="https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image003.png" alt="" srcset="https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image003.png 2528w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image003.png?resize=150,94 150w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image003.png?resize=300,188 300w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image003.png?resize=768,481 768w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image003.png?resize=680,426 680w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image003.png?resize=1536,962 1536w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image003.png?resize=2048,1283 2048w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image003.png?resize=50,31 50w" layout="intrinsic" i-amphtml-layout="intrinsic"><i-amphtml-sizer class="i-amphtml-sizer"><img alt="" aria-hidden="true" class="i-amphtml-intrinsic-sizer" role="presentation" src=""/></i-amphtml-sizer><noscript><img aria-describedby="caption-attachment-2266722" loading="lazy" class="size-full wp-image-2266722" src="../Images/8a8cd76f710b9eb1d3b958f5a7126ce9.png" alt="" srcset="https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image003.png 2528w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image003.png?resize=150,94 150w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image003.png?resize=300,188 300w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image003.png?resize=768,481 768w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image003.png?resize=680,426 680w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image003.png?resize=1536,962 1536w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image003.png?resize=2048,1283 2048w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image003.png?resize=50,31 50w" sizes="(max-width: 1024px) 100vw, 1024px" data-original-src="https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image003.png"/></noscript></amp-img><p id="caption-attachment-2266722" class="wp-caption-text translated">Koneksa 帕金森氏症震颤评估工具。<strong>图片来源:</strong> Koneksa</p></div>
<p class="translated">Koneksa 如何将模拟秤转变为数字秤？帕金森病就是一个明显的例子。用于评估帕金森病患者的一个常见的<a href="https://web.archive.org/web/20220411000554/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545638/" target="_blank" rel="noopener">但不完善的</a>指标被称为统一帕金森病评级量表——这是一个由多个部分组成的考试，结合了关于情绪、日常生活和症状的问卷，以及临床评估，如运动测试。</p>
<p class="translated">为了量化震颤，医生可能会要求患者<a href="https://web.archive.org/web/20220411000554/https://www.youtube.com/watch?v=cxHpFWKIfGw" target="_blank" rel="noopener">伸出一只手臂</a>，并尽可能快地上下翻转手掌。同时，临床医生观察该运动的速度或形状的细微变化。相反，Koneksa 方法是让病人拿着他们的手机，做同样的动作。手机的加速度计和陀螺仪记录这些变化，并将数据传输到该公司的平台。</p>
<p class="translated">在幕后，该公司的算法对这种颤动进行“评分”，类似于医生在检查后可能会给出的分数。</p>
<p class="translated">首席执行官克里斯·本科告诉 TechCrunch 说:“这些传感器的潜力是更细粒度的，我谨慎地使用这个词，更客观地解读一个人的震颤——我们的技术有巨大的潜力。”。</p>
<p class="translated">用高科技改造模拟<a href="https://web.archive.org/web/20220411000554/https://techcrunch.com/2021/09/15/patient-monitoring-startup-doccla-secures-3-3m-seed-funding-for-virtual-wards-platform/">病人监护</a> <a href="https://web.archive.org/web/20220411000554/https://techcrunch.com/2022/01/04/kiddo-picks-up-16mfor-a-kids-wearable-aimed-at-four-chronic-conditions/">技术</a>的想法已经吸引了很多公司。Koneksa 当然在那个世界里玩，但它并不仅仅着眼于软件。它在证明数字生物标记可靠性的整个论点之后——如果不是至高无上的话。</p>
<p class="translated">如果手机能够捕捉到医生可能会忽略的微小手部动作，那就太好了。但是这些手部动作真的代表颤抖吗？而且，这些数字化测试真的能告诉医生病人以后的情况吗？</p>
<p class="translated">为了知道这些问题的答案，数字生物标志物需要经过临床验证。没有这种验证，这样的工具最终在临床试验中毫无用处。</p>
<p class="translated">“我们希望专注于把关问题，这对于将新疗法推向市场非常重要，然后找出如何进行科学验证，证明这些技术工具比现有技术更好或相当。我们必须按照世界领先制药公司的标准来做，”Benko 说。</p>
<p class="translated">这种验证是 Koneksa 目前的重点。在这方面，该公司已经能够证明在家测量与在诊所进行的测试确实相关。</p>
<p class="translated"><span class="embed-youtube embed breakout embed--video amp-wp-ad18994" data-amp-original-style="text-align:center; display: block;"><amp-youtube data-videoid="cxHpFWKIfGw" data-param-rel="1" data-param-showsearch="0" data-param-showinfo="1" data-param-iv_load_policy="1" data-param-fs="1" data-param-hl="en-US" data-param-autohide="2" data-param-wmode="transparent" layout="responsive" class="i-amphtml-layout-responsive i-amphtml-layout-size-defined" i-amphtml-layout="responsive"><i-amphtml-sizer/><a href="https://web.archive.org/web/20220411000554/https://www.youtube.com/watch?v=cxHpFWKIfGw" placeholder=""><amp-img src="https://web.archive.org/web/20220411000554im_/https://i.ytimg.com/vi/cxHpFWKIfGw/hqdefault.jpg" alt="YouTube Poster" layout="fill" object-fit="cover" class="i-amphtml-layout-fill i-amphtml-layout-size-defined" i-amphtml-layout="fill"><noscript><img src="../Images/55c2079b6ca369f4991f11c6a69dd365.png" loading="lazy" decoding="async" alt="YouTube Poster" data-original-src="https://web.archive.org/web/20220411000554im_/https://i.ytimg.com/vi/cxHpFWKIfGw/hqdefault.jpg"/></noscript></amp-img></a></amp-youtube>T11】</span></p>
<p class="translated"><a href="https://web.archive.org/web/20220411000554/https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A3934" target="_blank" rel="noopener">例如，一项针对 12 名哮喘患者的研究</a>显示，家用肺活量计的读数与诊所的读数相当。Benko 指出，患者确实犯了一些错误，但因为他们能够更频繁地进行测试，研究人员最终获得了更多的数据。</p>
<p class="translated">该研究指出，典型的哮喘临床试验需要招募约 100 名患者才能获得有意义的结果。使用家庭测试，作者认为他们只需要 18 个人就可以得到同样的结果。“这就是制药公司在经济上感兴趣的地方，”Benko 说。“但对病人来说，他们只是说，这更方便，更真实。”</p>
<p class="translated">该公司还能够提出一个令人信服的案例，即家庭患者数据可能会产生有临床意义的见解。例如，该公司对 66 名头颈癌患者进行了一项研究，他们使用可穿戴设备来测量每天的步数。</p>
<p class="translated">研究发现，每走 1000 步，患者面临的住院风险就会降低 26%。然而，正如 Benko 指出的，是他们在周末的活动(即患者自己选择的运动)揭示了这一统计数据，而不是他们因为工作日的责任而坚持的运动时间表。</p>
<p class="translated">这项研究在 2021 年美国临床肿瘤学会会议上发表，但没有在杂志上发表。</p>
<p class="translated">尽管如此，临床有效性的最终决定者，至少在开发药物时，是 FDA。Koneksa 的下一步将是证明这些生物标志物足够可靠，足以将它们整合到监管决策过程中。</p>
<p class="translated">Wagner 说:“我们现在正在做的是 Koneksa 拥有的或 Koneksa 与学术界合作的研究，以推动临床验证的发展。”。</p>
<p/><div id="attachment_2266916" class="wp-caption aligncenter amp-wp-9a5936b" data-amp-original-style="width: 690px"><amp-img aria-describedby="caption-attachment-2266916" class="size-large wp-image-2266916 amp-wp-enforced-sizes i-amphtml-layout-intrinsic i-amphtml-layout-size-defined" src="https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image001-1-3.png?w=680" alt="" srcset="https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image001-1-3.png 1261w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image001-1-3.png?resize=150,121 150w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image001-1-3.png?resize=300,243 300w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image001-1-3.png?resize=768,622 768w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image001-1-3.png?resize=680,551 680w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image001-1-3.png?resize=50,40 50w" layout="intrinsic" i-amphtml-layout="intrinsic"><i-amphtml-sizer class="i-amphtml-sizer"><img alt="" aria-hidden="true" class="i-amphtml-intrinsic-sizer" role="presentation" src=""/></i-amphtml-sizer><noscript><img aria-describedby="caption-attachment-2266916" loading="lazy" class="size-large wp-image-2266916" src="../Images/f1ad9d2a0fbab166c84fc1aaa300c91f.png" alt="" srcset="https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image001-1-3.png 1261w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image001-1-3.png?resize=150,121 150w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image001-1-3.png?resize=300,243 300w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image001-1-3.png?resize=768,622 768w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image001-1-3.png?resize=680,551 680w, https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image001-1-3.png?resize=50,40 50w" sizes="(max-width: 680px) 100vw, 680px" data-original-src="https://web.archive.org/web/20220411000554im_/https://techcrunch.com/wp-content/uploads/2022/02/image001-1-3.png?w=680"/></noscript></amp-img><p id="caption-attachment-2266916" class="wp-caption-text translated">Koneksa 的全套措施。<strong>图片来源:</strong> Koneksa</p></div>
<p class="translated">至于 C 系列里程碑，Koneksa 有两个目标。</p>
<p class="translated">首先是增加支持他们的数字生物标记管道的证据。在过去，该公司一直与制药合作伙伴一起寻找数字生物标志物并对其进行验证。在这些合作之前完成验证将使 Koneksa 更快地启动新程序。</p>
<p class="translated">第二部分是推出一个被 Benko 称为“自助服务”的平台。这个自助服务平台允许新合作伙伴将来自多个设备和可穿戴设备的数据整合到同一个地方，并将其组织到一个仪表板中。</p>
<p class="translated">“我们认识到，该软件在临床试验环境中整合[不同]设备数据的能力是独一无二的。市场上没有其他类似的资产。那么我们为什么要控制它的每一个可能的用途呢？我们希望能够打开它说:‘嘿，我们可以把这个平台授权给你。’"</p>
<p class="translated">尽管这两个目标在操作上是不同的，但它们确实有相似之处。Koneksa 希望将他们的数字生物标记和平台转变为交钥匙解决方案。</p>
<p class="translated">本轮由矩阵资本管理公司管理的基金 AyurMaya 领投，武田创投和 Velosity Capital 参与。现有投资者 McKesson Ventures、默克全球健康创新基金、诺华(dRx Capital)、Spring Mountain Capital 和 Waterline Ventures 也参与了该轮投资。</p>

		

			
	
		

			<amp-pixel src="https://web.archive.org/web/20220411000554im_/https://ampmetrics.techcrunch.com/pixel.gif" placeholder="" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>
		<amp-analytics data-credentials="include" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed">
		
	</amp-analytics>
		<amp-pixel src="https://web.archive.org/web/20220411000554im_/https://pixel.wp.com/g.gif?v=ext&amp;j=1%3A10.8&amp;blog=136296444&amp;post=2266400&amp;tz=-7&amp;srv=techcrunch.com&amp;host=techcrunch.com&amp;rand=RANDOM&amp;ref=DOCUMENT_REFERRER" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>
	<amp-analytics id="tc_googleanalytics" type="googleanalytics" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_comscore" type="comscore" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_parsely" type="parsely" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>	</div>

</div>    
</body>
</html>